Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Cord Blood Mononuclear Cell for Delayed Encephalopathy After Carbon Monoxide Poisoning
NCT02952716Phase 2Unknown
- Sponsor
- Liaocheng City People's Hospital
- Start
- Oct 2016
- Primary completion
- Oct 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of umbilical cord blood mononuclear cells in Delayed encephalopathy after carbon monoxide poisoning (DNS) (2 arms), sponsored by Liaocheng City People's Hospital. Primary endpoint: Mini-Mental State Examination at 24 weeks. Status: unknown.
02
Drugs
umbilical cord blood mononuclear cells
03
Conditions
Delayed encephalopathy after carbon monoxide poisoning (DNS)
Beyond the preview
Go deeper on NCT02952716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02952716.